Companies /Healthcare
Relay Therapeutics Inc
NASDAQ: RLAY Biotechnology
$17.06
▼ $0.30 (−1.73%) today
Markets closed · 9:25pm ET

Relay Therapeutics (RLAY) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
60%
EPS beat rate
+2.64%
Avg. EPS surprise
Consecutive EPS misses
RLAY vs Market · 30-day return after each reportRLAYS&P 500
0%+9%+18%+27%+6.7%+7.2%Q1 25+26.1%+2.4%Q2 25+25.5%+2.5%Q3 25−3.0%−5.2%Q4 25+5.7%+0.7%Q1 26
0%+9%+18%+27%Q1 25Q2 25Q3 25Q4 25Q1 26
RLAY EPS Trend · estimate vs actualEstimateActual
$-0.40$-0.20$-0.48$-0.46Q1 25$-0.44$-0.41Q2 25$-0.42$-0.43Q3 25$-0.40$-0.32Q4 25$-0.36$-0.41Q1 26
$-0.40$-0.20Q1 25Q2 25Q3 25Q4 25Q1 26
RLAY Revenue Trend · estimate vs actualEstimateActual
$0$3.0M$6.0M$11,110$7.7MQ1 25$14,290$677,000Q2 25$4.3M$7.0MQ4 25$4.7M$3.0MQ1 26
$0$3.0M$6.0MQ1 25Q2 25Q4 25Q1 26

How Often Does Relay Therapeutics Beat Earnings Estimates?

Relay Therapeutics beat EPS estimates in 3 of its last 5 reported quarters.

RLAY quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q1 2026 $-0.41 est. $-0.36 −15.01% $3.0M est. $4.7M −35.48%
Q4 2025 $-0.32 est. $-0.40 +19.17% $7.0M est. $4.3M +61.41%
Q3 2025 $-0.43 est. $-0.42 −2.75% — —
Q2 2025 $-0.41 est. $-0.44 +7.66% $677,000 est. $14,290 +4,637.58%
Q1 2025 $-0.46 est. $-0.48 +4.11% $7.7M est. $11,110 +69,017.91%

Figures from SEC filings and company reports. Not investment advice.